Bromocriptine use is associated with decreased smoking rates.

Bromocriptine use is associated with decreased smoking rates.

Dopaminergic transmission in the central nervous system is thought to underlie addictive behaviours, including smoking. One effective smoking cessation drug, bupropion, enhances dopaminergic transmission; conversely, antipsychotic drugs, which are dopamine antagonists, are associated with increased...

Podrobná bibliografie
Hlavní autoři:	Murphy, M, Hey, K, Johnstone, E, Munafo, M, Walton, R, Willis, B, Harrison, P
Médium:	Journal article
Jazyk:	English
Vydáno:	2002

Podobné jednotky

Association of the mu-opioid receptor gene with smoking cessation.
Autor: Munafò, MR, a další
Vydáno: (2007)

The genetic basis for smoking behavior: a systematic review and meta-analysis.
Autor: Munafò, M, a další
Vydáno: (2004)

Association of COMT Val108/158Met genotype with smoking cessation in a nicotine replacement therapy randomized trial.
Autor: Johnstone, E, a další
Vydáno: (2007)

Association of COMT Val108/158Met genotype with smoking cessation.
Autor: Munafò, MR, a další
Vydáno: (2008)

Central Hyperthermia Treated with Bromocriptine
Autor: P. Natteru, a další
Vydáno: (2017-01-01)

Does cigarette smoking increase time to conception?
Autor: Munafo, M, a další
Vydáno: (2002)

Zyban for smoking cessation in a general practice setting: the response to an invitation to make a quit attempt.
Autor: Johnstone, E, a další
Vydáno: (2004)

Is giving up smoking on the nicotine patch related to genotype?
Autor: Yudkin, P, a další
Vydáno: (2001)

Smoking cessation, weight gain, and DRD4 -521 genotype
Autor: Munafò, MR, a další
Vydáno: (2006)

Cabergoline or bromocriptine for prolactinoma?
Autor: Nicolás Triantafilo, a další
Vydáno: (2016-09-01)

Lack of association of DRD2 rs1800497 (Taq1A) polymorphism with smoking cessation in a nicotine replacement therapy randomized trial
Autor: Munafo, M, a další
Vydáno: (2009)

Lack of association of DRD2 rs1800497 (Taq1A) polymorphism with smoking cessation in a nicotine replacement therapy randomized trial.
Autor: Munafò, MR, a další
Vydáno: (2009)

Smoking status moderates the association of the dopamine D4 receptor (DRD4) gene VNTR polymorphism with selective processing of smoking-related cues.
Autor: Munafò, MR, a další
Vydáno: (2008)

Genetic variation in the dopamine D4 receptor (DRD4) gene and smoking cessation: follow-up of a randomised clinical trial of transdermal nicotine patch.
Autor: David, S, a další
Vydáno: (2008)

Lack of association of OPRM1 genotype and smoking cessation.
Autor: Munafò, MR, a další
Vydáno: (2013)

Genes and cigarette smoking.
Autor: Munafò, MR, a další
Vydáno: (2008)

No association between functional catechol O-methyl transferase 1947A>G polymorphism and smoking initiation, persistent smoking or smoking cessation.
Autor: David, S, a další
Vydáno: (2002)

Bromocriptine in the Management of Central Hyperthermia
Autor: Krishnaprasad Narayanankutty, a další
Vydáno: (2024-08-01)

Repurposing of Bromocriptine for Cancer Therapy
Autor: Ean-Jeong Seo, a další
Vydáno: (2018-10-01)

Effectiveness of nicotine patches in relation to genotype in women versus men: randomised controlled trial.
Autor: Yudkin, P, a další
Vydáno: (2004)

Bromocriptine Use in Peripartum Cardiomyopathy: Review of Cases
Autor: Rebecca Simon, a další
Vydáno: (2018-10-01)

Bromocriptine and insulin sensitivity in lean and obese subjects
Autor: L Bahler, a další
Vydáno: (2016-11-01)

DEPOT BROMOCRIPTINE IN THE TREATMENT OF PROLACTINOMAS AND ACROMEGALY
Autor: Grossman, A, a další
Vydáno: (1985)

Depot-bromocriptine treatment for prolactinomas and acromegaly.
Autor: Grossman, A, a další
Vydáno: (1986)

Bromocriptine for type 2 diabetes mellitus
Autor: Ooi, Cheow Peng, a další
Vydáno: (2013)

Bromocriptine in type 2 diabetes mellitus
Autor: C Shivaprasad, a další
Vydáno: (2011-01-01)

Association between nicotinic acetylcholine receptor single nucleotide polymorphisms and smoking cessation.
Autor: Spruell, T, a další
Vydáno: (2012)

Pharmacogenetics of smoking cessation in general practice: results from the patch II and patch in practice trials.
Autor: David, S, a další
Vydáno: (2011)

Abstinence from smoking eight years after participation in randomised controlled trial of nicotine patch.
Autor: Yudkin, P, a další
Vydáno: (2003)

CHRNA3 rs1051730 genotype and short-term smoking cessation.
Autor: Munafò, MR, a další
Vydáno: (2011)

A peripartum cardiomyopathy case treated with bromocriptine
Autor: Dilek Yeşilbursa, a další
Vydáno: (2021-03-01)

A comparison of cabergoline and bromocriptine in the treatment of hyperprolactinemic amenorrhea
Autor: Ismail, I.S., a další
Vydáno: (1994)

Dopaminergic agonist bromocriptin in treatment of diabetes mellitus type 2
Autor: O A Gerasimenko, a další
Vydáno: (2011-12-01)

Maternal smoking during late pregnancy and offspring smoking behaviour.
Autor: Munafò, MR, a další
Vydáno: (2006)

Genome-wide association for smoking cessation success: participants in the Patch in Practice trial of nicotine replacement.
Autor: Uhl, G, a další
Vydáno: (2010)

Effects of dopamine D2 receptor gene polymorphisms on smoking cessation: Abstinence and withdrawal symptoms
Autor: Munafo, MR, a další
Vydáno: (2007)

Bromocriptine inhibits proliferation in the endometrium from women with adenomyosis
Autor: Yiqun Tang, a další
Vydáno: (2023-03-01)

The rapid diagnosis of sensitivity or resistance to dopamine agonists with depot bromocriptine.
Autor: Grossman, A, a další
Vydáno: (1987)

Weekly versus basic smoking cessation support in primary care: a randomised controlled trial.
Autor: Aveyard, P, a další
Vydáno: (2007)

The serotonin transporter 5-HTTLPR polymorphism and treatment response to nicotine patch: follow-up of a randomized controlled trial.
Autor: David, S, a další
Vydáno: (2007)